Cite Filings / FENC / 0001493152-26-047509

Feed Companies Filings Check

Sign in

SCHEDULE 13G/A

Statement of Beneficial Ownership

FENNEC PHARMACEUTICALS INC. Filed 2026-10-19 Acc 0001493152-26-047509

Documents 1

SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

2026-10-19 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-10-13 4 Chief Strategy Officer acquired 3,946 shares (grant or award)
2026-10-13 4 Chief Medical Officer acquired 3,846 shares (grant or award)
2026-10-13 4 Chief Commercial Officer acquired 2,326 shares (grant or award)
2026-10-13 4 Chief Executive Officer acquired 2,224 shares (grant or award)
2026-10-13 4 CHIEF FINANCIAL OFFICER acquired 3,846 shares (grant or award)
2026-08-14 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…